<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="brief-report" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Open Forum Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">Open Forum Infect Dis</journal-id><journal-id journal-id-type="pmc-domain-id">2604</journal-id><journal-id journal-id-type="pmc-domain">ofid</journal-id><journal-id journal-id-type="publisher-id">ofid</journal-id><journal-title-group><journal-title>Open Forum Infectious Diseases</journal-title></journal-title-group><issn pub-type="epub">2328-8957</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10394719</article-id><article-id pub-id-type="pmcid-ver">PMC10394719.1</article-id><article-id pub-id-type="pmcaid">10394719</article-id><article-id pub-id-type="pmcaiid">10394719</article-id><article-id pub-id-type="pmid">37539059</article-id><article-id pub-id-type="doi">10.1093/ofid/ofad389</article-id><article-id pub-id-type="publisher-id">ofad389</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Brief Report</subject></subj-group><subj-group subj-group-type="category-taxonomy-collection"><subject>AcademicSubjects/MED00290</subject></subj-group></article-categories><title-group><article-title>Low Rates of Antifungal Therapeutic Drug Monitoring Among Inpatients Who Received Itraconazole, Posaconazole, or Voriconazole, United States, 2019&#8211;2021</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0458-2493</contrib-id><name name-style="western"><surname>Benedict</surname><given-names initials="K">Kaitlin</given-names></name><aff>
<institution>Mycotic Diseases Branch, Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention</institution>, <addr-line>Atlanta, Georgia</addr-line>, <country country="US">USA</country></aff><xref rid="ofad389-cor1" ref-type="corresp"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gold</surname><given-names initials="JAW">Jeremy A W</given-names></name><aff>
<institution>Mycotic Diseases Branch, Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention</institution>, <addr-line>Atlanta, Georgia</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5904-6658</contrib-id><name name-style="western"><surname>Toda</surname><given-names initials="M">Mitsuru</given-names></name><aff>
<institution>Mycotic Diseases Branch, Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention</institution>, <addr-line>Atlanta, Georgia</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Thompson</surname><given-names initials="GR">George R</given-names><suffix>III</suffix></name><aff>
<institution>Department of Internal Medicine, Division of Infectious Diseases, University of California, Davis Medical Center</institution>, <addr-line>Sacramento, California</addr-line>, <country country="US">USA</country></aff><aff>
<institution>Department of Medical Microbiology and Immunology, University of California</institution>, <addr-line>Davis, California</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wiederhold</surname><given-names initials="NP">Nathan P</given-names></name><aff>
<institution>Fungus Testing Laboratory, Department of Pathology and Laboratory Medicine, University of Texas Health Science Center at San Antonio</institution>, <addr-line>San Antonio, Texas</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Smith</surname><given-names initials="DJ">Dallas J</given-names></name><aff>
<institution>Mycotic Diseases Branch, Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention</institution>, <addr-line>Atlanta, Georgia</addr-line>, <country country="US">USA</country></aff><aff>
<institution>Epidemic Intelligence Service, Centers for Disease Control and Prevention</institution>, <addr-line>Atlanta, Georgia</addr-line>, <country country="US">USA</country></aff><xref rid="ofad389-cor1" ref-type="corresp"/><xref rid="ofad389-FM1" ref-type="author-notes"/></contrib></contrib-group><author-notes><corresp id="ofad389-cor1">Correspondence: Kaitlin Benedict, MPH, Mycotic Diseases Branch, Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H24-9, Atlanta, GA 30329, USA (<email>jsy8@cdc.gov</email>); Dallas J. Smith, Mycotic Diseases Branch, Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H24-9, Atlanta, GA 30329, USA (<email>rhq8@cdc.gov</email>).</corresp><fn id="ofad389-FM1" fn-type="COI-statement"><p>
<bold>
<italic toggle="yes">Potential conflicts of interest</italic>.</bold> All authors: No reported conflicts.</p></fn></author-notes><pub-date pub-type="collection"><month>8</month><year>2023</year></pub-date><pub-date pub-type="epub" iso-8601-date="2023-07-20"><day>20</day><month>7</month><year>2023</year></pub-date><volume>10</volume><issue>8</issue><issue-id pub-id-type="pmc-issue-id">442040</issue-id><elocation-id>ofad389</elocation-id><history><date date-type="received"><day>19</day><month>5</month><year>2023</year></date><date date-type="editorial-decision"><day>17</day><month>7</month><year>2023</year></date><date date-type="accepted"><day>19</day><month>7</month><year>2023</year></date><date date-type="corrected-typeset"><day>02</day><month>8</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>20</day><month>07</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>03</day><month>08</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-09-01 16:25:16.217"><day>01</day><month>09</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>Published by Oxford University Press on behalf of Infectious Diseases Society of America 2023.</copyright-statement><copyright-year>2023</copyright-year><license><license-p>This work is written by (a) US Government employee(s) and is in the public domain in the US.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="ofad389.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ofad389.pdf"/><abstract><title>Abstract</title><p>Antifungal therapeutic drug monitoring (TDM) is recommended for hospitalized patients receiving itraconazole, posaconazole, or voriconazole for treatment or prophylaxis. In this analysis of hospital-based data, TDM was uncommonly performed (15.8%) in a large cohort of eligible patients, suggesting missed opportunities to avoid subtherapeutic drug levels and minimize toxicity.</p></abstract><kwd-group><kwd>drug monitoring</kwd><kwd>itraconazole</kwd><kwd>posaconazole</kwd><kwd>United States</kwd><kwd>voriconazole</kwd></kwd-group><counts><page-count count="4"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>